
Enable job alerts via email!
An NHS healthcare provider seeks a Band 5 Biomedical Scientist in Nuneaton. Responsibilities include performing diagnostic services, managing lab data, and ensuring quality outputs. Mandatory HCPC registration and NHS experience required. Join a supportive team dedicated to quality healthcare and professional development.
An opportunity has arisen within the Biochemistry and Immunology Department of Coventry and Warwickshire Pathology Services for a Band 5 Biomedical Scientist based in Nuneaton. The post sits primarily in the Immunology Department and is part of one of the largest NHS pathology providers in the Midlands, supporting four acute hospitals, the local GP network and over 250 practices.
The successful applicant will work closely with laboratory staff in a busy but friendly environment and will be responsible for delegated tasks that form part of a fit‑for‑purpose medical laboratory service. This includes analysing and reporting on blood, urine and other body fluids to support efficient, effective patient care and resource management.
• HCPC registration and relevant NHS experience are mandatory. Applicants must provide an immunisation and vaccination report from their current UK occupational health provider or their GP.
• Subject to contract, training and competence assessment, the post holder may discharge analytical duties either working alone or as part of a small team.
The position offers the opportunity to work with state‑of‑the‑art analysers and be part of a team dedicated to delivering high‑quality, first‑class Biochemistry and Immunology services. You will gain exposure to a wide range of learning and development opportunities and be part of an organisation that values diversity, equality and the full use of talent.
We are proud to be recognised as a Pathway to Excellence® designated organisation, providing an environment where fairness, respect, dignity and autonomy are promoted as core values.
Please apply as soon as possible; this advert will close on Friday 14 Nov 2025.